Top compounds associated with response to FAAP20


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.03
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.08 0.03
mRNA paclitaxel CCLE pan-cancer AAC 0.096 0.03
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.071 0.03
mRNA XMD11-85h GDSC1000 pan-cancer AAC -0.1 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.03
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA Erlotinib CCLE pan-cancer AAC -0.096 0.03
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.071 0.03
mRNA lapatinib GDSC1000 pan-cancer AAC -0.1 0.03
Download CSV